Product Details
Product Details
Product Specification
| Antigen | IP-10/CXCL10 |
| Reactivity | Monkey |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8°C as supplied. |
Kit
| Precision | Intra-assay: 3.65%; Inter-assay: 5.87% |
| Sample type | Serum; Plasma; Cell culture supernatant |
| Assay type | Sandwich (quantitative) |
| Sensitivity | 102.597 pg/mL |
| Range | 97.66 - 50000 pg/mL |
| Recovery | Plasma: 96.54% Serum: 75.12% Cell culture supernatant: 105.21% |
| Assay time | 70 minutes |
| Species reactivity | Monkey |
Background
Interferon-gamma-inducible protein 10 (IP-10), officially designated CXCL10, is a small chemokine belonging to the CXC subfamily. It is secreted by a broad range of cells—including monocytes, endothelial cells, keratinocytes, and fibroblasts—upon exposure to type I and type II interferons, particularly IFN-γ. IP-10 exerts its chemoattractant activity via the G protein-coupled receptor CXCR3, which is predominantly expressed on activated Th1 lymphocytes, NK cells, and CD8⁺ T cells. Through this axis, IP-10 orchestrates the recruitment of effector immune cells to inflamed or infected tissues, making it a critical player in antiviral immunity, tumor immunosurveillance, and the pathogenesis of Th1-driven autoimmune conditions such as multiple sclerosis, psoriasis, and type 1 diabetes. Monkey IP-10/CXCL10 denotes the orthologous protein from non-human primates, most commonly cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta). It shares exceptionally high amino acid identity with its human counterpart, preserving both receptor-binding affinity and biological activity across species. This high conservation underpins the extensive use of monkey IP-10 in preclinical pharmacology and toxicology studies, where it serves as a pharmacodynamic biomarker for immune activation and as a target for evaluating CXCR3-selective antagonists, monoclonal antibodies, and small-molecule inhibitors designed to modulate excessive inflammation.
